A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older
Clinical trial NCT03836924 · COMPLETED
Trial details
- NCT number
- NCT03836924
- Sponsor
- Eisai Pharmaceuticals India Pvt. Ltd
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-02-18
- Primary completion
- 2020-03-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.